Human amniotic epithelial cells (hAECs), derived from the innermost layer of the term placenta closest to the fetus, have been shown to be potential seed cells for allogeneic cell therapy. Previous studies have shown a certain therapeutic effect of hAECs. However, no appropriate isolation and culture system for hAECs has been developed for clinical applications. In the present study, we established a serum-free protocol for hAEC isolation and cultivation, in which better cell growth was observed compared with that in a traditional capacity. In a systemic safety evaluation, intravenous administration of hAEC did not result in hemolytic, allergy, toxicity issues or, more importantly, tumorigenicity. Finally, the therapeutic effect of hAECs was demonstrated in mice with radiation-induced damage. The results revealed a novel function of hAECs in systemic injury recovery. Therefore, the current study provides an applicable and safe strategy for hAEC cell therapy administration in the clinical setting.
Introduction
With the potential for replication and multidirectional differentiation, stem cells are some of the best candidates for cellular therapy and regenerative medicine. However, the transition from bench-side to bedside is challenged by tumorigenicity, immune responses, multi-step procedures and ethical concerns according to studies of embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSs) [1] [2] [3] . Although cell therapy using autologous stem cells circumvents some of these issues, maintaining quality control and industrial production [4] .
Recently, researchers have started to focus on the stem-like cells in the amniotic membrane (AM). The AM is the innermost layer of the placenta and is important for maternal-fetal material exchange. Human amnion epithelial cells (hAECs), isolated from the layer closest to the fetus in the term placenta, are considered a unique and ideal cell source for cell therapy [5] . Our previous study and other reports indicated that hAECs were pluripotent and could differentiate into three germ layers in vitro and in vivo [6] [7] [8] , which could be attributed to their derivation from the inner cell mass within the blastocyst at d 8 of fertilized egg development. OCT4, the key transcription factor for maintaining pluripotency and self-renewal in ESCs and iPSs, is expressed in hAECs [2, 7, 9] . Most of the other representative pluripotent stem cell markers, such as NANOG, SOX-2, SSEA-4, FGF-4, and REX-1, have also been detected in hAECs [7] . However, hAECs lack telomerase, resulting in a limited proliferative capacity [7] . On the other hand, particularly low expression of HLA class I molecules has been reported in hAECs [10, 11] , suggesting potential immune tolerance after transplantation. Furthermore, immuneregulatory properties of hAECs have been demonstrated in vitro and in animal models [12] [13] [14] , corresponding to the function of the AE in maintaining feto-maternal tolerance during pregnancy.
All of these qualities suggest that hAECs represent an excellent candidate for allogeneic cell therapy in the clinic. Indeed, several studies have revealed the therapeutic effects of hAECs for injury repair in ophthalmology [15] [16] [17] [18] [19] , wound healing [20, 21] [22] . However, an appropriate isolation and culture system for hAECs aimed at clinical applications is not currently available. In the present study, we established a serum-free protocol for hAEC isolation and cultivation. A systemic biological characterization and safety evaluation demonstrated the applicable properties and safety of cell therapy. In addition, the therapeutic capability of
Materials and methods
hAEC isolation and culture Human amnion membranes were obtained with written and informed consent from healthy mothers undergoing cesarean section. Human placentas were obtained from healthy mothers who provided written informed consent after uncomplicated elective cesarean section. The procedure was approved by the institutional patients and ethics committee of the International Peace Maternity and Child Health Hospital, Shanghai Jiaotong University School of Medicine. All donors were negative for hepatitis A, B, C, and D and HIV-I and TPAB (Treponema pallidum antibody). hAECs were isolated from the collected placentas. In brief, the amniotic membrane was peeled from the placental chorion and washed in HBSS (Hank's balanced salt solution) to remove blood cells. The amniotic membrane was digested with 0.25% trypsin (EDTA) for 30 min at 37 °C in a water bath. Two volumes of complete culture medium (F12/ DMEM, 10% KSR (KnockOut Serum Replacement), 2 mmol/L L -captoethanol, 1 mmol/L sodium pyruvate, 1% antibioticantimycotic (all from Gibco) and 10 ng/mL EGF (Peprotech) were added to the trypsin digestion medium, and the sample was centrifuged for 10 min at 300×g. The cell pellet was then suspended in the complete culture medium for the subsequent cell culture. The cultured P1-hAECs were then frozen in CELLBANKER (ZENOAQ, Fukushima, Japan) at a concentration of 5×10 6 /mL and stored in a refrigerator at -80 °C overnight. Then, frozen vials were transferred into liquid nitrogen for long-term preservation. hAECs were thawed by gently agitating the vial in a 37 °C water bath after 30 d of storage. Post-thaw cell viability was assessed by Trypan blue exclusion staining and compared with P1 human umbilical cord mesenchymal stem cells that were also frozen in CELLBANKER using the same method. For comparative study, some hAECs were isolated and cultured using traditional culture medium with 10% FBS (Gibco) instead of KnockOut Serum Replacement. Passages 1-3 of hAECs isolated from more than 3 different donors were utilized in this paper.
Flow cytometry
Cells were digested and then washed with PBS. The hAECs were stained using standard protocols with fluorescenceconjugated antibodies targeting CD34, CD45, CD31, CD29, CD166, CD90, HLA-DR, and HLA-DQ (1:20, all from BioLegend). For SSEA4 and TRA-1-60, hAECs were stained with the SSEA4 (1:20, Millipore) and TRA-1-60 (1:20, Millipore) primary antibodies and then incubated with fluorescence-conjugated secondary antibodies. Measurements of cell cycle distribution were obtained using propidium iodide (PI) staining. Flow cytometric analysis was performed with a FACS Calibur instrument (Becton Dickinson, Franklin Lakes, NJ, USA). Isotype controls were used in each experiment.
for 30 min on ice. The cells were then incubated in 0.2% Triton X-100 (in PBS) for 30 min and blocked in 3% horse serum for 1 h at room temperature. Primary antibodies against Cytokeratin (1:200, Abcam), E-cadherin (1:200, Abcam), OCT4 (1:50, Santa Cruz), SSEA4 (1:100, Millipore), and NANOG (1:40, R&D Systems) were incubated with cells for 12 h at 4 °C, followed by incubation with secondary antibodies for another 1 h at room temperature. Nuclei were stained with DAPI.
Cytokine assay
The culture medium was collected after hAECs and PBMCs were cultured alone or after hAECs were co-cultured with PBMC for 3 d. PHA (5 ug/mL, Sigma) was added into the medium to activate the PBMCs. Cytokines in the medium IL17, IL10 and IL2 (all from eBioscience), according to the manufacturer's instructions.
Mice
All animal studies were approved by the Institutional Animal Care and Use Committee of Zhejiang University and adhered to the Guide for the Care and Use of Laboratory Animals. NOD/SCID (Non-Obese Diabetic/Severe Combined Immunodepurchased from Model Animal Research Center of Nanjing University (Nanjing, China), and all the other animals were purchased from Slac Laboratory Animal (Shanghai, China). The animals were acclimated to the room for one week after arrival and were maintained on a normal 12-h light-dark cycle. The animals were housed in conventional cages with free access to a standard pellet -perature of 24±2 °C and 60%-70% relative humidity. Standard wood chips for mice were used as bedding material.
Toxicity test
Eight-week-old male/female ICR mice were used to determine every 3 d for 7 weeks. The death of mice was also recorded in both assays. The tumor cell lines B16-F10, HeLa and Raji were purchased from Cell Resource Center of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences.
Reverse transcription-PCR Total RNA was isolated using an ENZA total RNA Kit (Omega) according to the manufacturer's instructions. cDNAs were generated using a ReverTra Ace qPCR RT kit (Toyobo). Reverse transcription-PCR (RT-PCR) was performed with TaqMix (VWI Science). The primer sequences are listed below: hTERT-F, 5'-AGAGTGTCTGGAGCAAGTTGC-3' and hTERT-R, 5'-CGTAGTCCATGTTCACAATCG-3'; 5'-TTCTCCTTGATGTCACGCAC-3'.
Radiation-induced damage model
The NOD/SCID mice were given 2.7 Gy of total body irradiation. Then, 2×10
6 hAECs were transplanted into the mice via iv injection. Body weight and the clinical phenotype, including energy loss, diarrhea, hunching and ruffled hair, were recorded every other day.
Hematoxylin and eosin staining and histological analysis
The mice were sacrificed on d 14 after irradiation, and the -and stained with hematoxylin and eosin. Histopathologifrom Polchert et al [23] . The scores for lungs and intestines are defined as follows: for the lung, 0=normal; 1.0=perivascular 2.0=perivascular cuffing, 2-3 cells in thickness, involving up 50% of vessels, and infiltration into the parenchyma proper; than 50% of vessels, peribronchiolar cuffing (>6 cells), and infiltration into the parenchyma proper with severe disruption of structure; for the intestine, 0=normal; 1.0=necrotic cells lamina propria (1-2-cell thickness in intermucosal areas and -tion of less than or equal to one-third of the lamina propria (3-cell thickness in intermucosal areas and the submucosa); lamina propria (5-6-cell thickness in intermucosal areas and -pria resulting in displacement of more than 50% of the mucosa with loss of 75%-100% of goblet cells.
Statistical analysis
The statistical analysis was performed using GraphPad Prism 5 (GraphPad Software, Inc, San Diego, CA, USA). The the most tolerance dose (MTD), and the no observed adverse effect level (NOAEL) was based on clinical observations, general tissue dissection and survival records. Furthermore, acute toxicity tests of hAECs were performed in ICR mice via single iv injection of hAECs (low dose 2.5×10 7 cells/kg, medium dose 5×10 7 cells/kg or high dose 1×10 8 cells/kg) according to the mouse equivalent dose and the MTD. Clinical observations of the toxicity response, including mouse behavior, mental state, mortality and body weight, and gross dissection were evaluated within 14 d. To evaluate the long-term toxicity of hAECs in vivo, 6-to 8-week-old SD rats were subjected to iv injection of hAECs (low dose 2.5×10 7 cells/kg or high dose 5×10 7 cells/kg) every two weeks 3 times. Routine blood parameters, blood biochemistry, the coagulation index, hAEC organ distribution, mouse body weight and viscera weight, general tissue histology, cytokine levels, and T cell populations were examined 6 weeks after transplantation.
Hemolysis test hAECs were diluted using 0.9% NaCl in an ascending gradient from 1:24 to 1:4 (v:v) to achieve hAEC numbers from 10 6 to 5×10 6 . Diluted hAECs were then co-incubated with 2% rabbit red blood cell suspension in 0.9% NaCl at 37 °C for 3 h. Red blood cells incubated with ddH 2 O or 0.9% NaCl were used as positive and negative controls, respectively. The hemolysis and coagulation of red blood cells in each sample were observed and recorded every 15 min for 3 h.
Allergy test
Vital River Laboratory Animal Technology (Beijing, China), were randomly divided into 4 groups (6 animals per group) that were given 0.5 mL of saline, 5 mg of BSA, 1.0×10 6 hAECs or 2.0×10 6 hAECs three times per animal by intraperitoneal injection. Fourteen days after the last sensitization, 3 animals in each group were subjected to the first-batch allergy challenge. If the result was negative, then the remaining animals were subjected to the second-batch allergy challenge 21 d after the last sensitization. Allergic reactions were assessed according to the following symptoms: dysphoria, piloerection, trembling, nose scratching, sneezing, cough, polypnea, urination, defecation, lacrimation, dyspnea, wheezing, purpura, gait instability, jumping, gasping, spasms, spinning, CheyneStokes breathing and death.
Tumorigenicity assay
To investigate the tumorigenicity of hAECs, NOD/SCID mice were divided randomly into 4 groups (10 mice in each group) that were given either 2×10 6 (low dose) or 4×10 6 (high dose) hAECs, 1.75×10 6 B16-F10 cells or 0.9% NaCl per mouse. Then, the tumor volume and mouse weight were measured every 3 d for 4 months. To investigate whether hAECs affect tumor growth, the NOD/SCID mice were subjected to co-injection of 5×10 4 (low dose), 5×10 5 (medium dose) or 5×10 6 (high dose) hAECs with 3×10 6 HeLa tumor cells or 3×10 6 Raji tumor cells. Then, the tumor volume and mouse weight were measured data are presented as the mean±SEM. The data for these measurements were analyzed using Student's t-test or twoway ANOVA. P values <0.05 were considered to indicate
Results
The biological features of hAECs in a serum-free system In the present study, hAECs were isolated and cultured in a serum-free system as described in "Materials and methods". The morphology of hAECs isolated in the serum-free system showed the typical cobblestone-like shape of epithelial cells ( Figure 1A) . CD34, CD45 and CD31 on the isolated cells were barely detectable ( Figure 1B) , and the cells stained positive for the epithelial markers cytokeratin and E-cadherin ( Figure  1C ), suggesting that hAECs isolated by our system were not contaminated with blood cells, endothelial cells or amniotic mesenchymal cells. In addition, regarding epithelial markers, hAECs exhibited full expression of CD29 and CD166 and moderate CD90 expression ( Figure 1D , Table 1 ). In the traditional culture system with serum, the growth of hAECs started to slow down around P2 and obviously appeared inhibited around P3. In contrast, the hAECs in the serumfree system demonstrated a steep growth curve after P1 and a higher total cell yield around P3, although the cell yield was lower before P2 ( Figure 1E ). These results indicated that the serum-free culture system established in the present study was superior to the traditional serum culture system in delaying hAEC senescence and maintaining their proliferation ability. In addition, serum-free cryopreservation was employed in our system. Most hAECs were detected alive after storage for 30 d followed by thawing, while a significant decrease in the survival rate was observed in human mesenchymal stem cells (hMSCs) ( Figure 1F) . Importantly, the classical pluripotent markers OCT4, NANOG, SSEA4 and TRA-1-60 serum-free system ( Figure 1G ). Compared with hMSCs, the hAECs expressed even higher levels of the major pluripotent markers ( Figure 1H ). The cell cycle assay of hAECs revealed typical quiescence, similar to that of most stem cells ( Figure  1I ). On the other hand, very low levels of HLA-DR and HLA-DQ were detected, indicating weak immunogenicity of the hAECs ( Figure 1J ). Taken together, the data demonstrated that the hAECs isolated and cultured with the serum-free system were homogeneous and showed robust propagation and maintained pluripotency.
The immunoregulatory properties of hAECs and functional
To identify the potential immunoregulatory function of hAECs, hAECs were co-cultured with PHA-activated PBMCs. were sequentially screened and were found to be expressed at different abundance levels in the hAECs cultured in the IL17 and IL2 were down regulated, while the anti-inflammatory factor IL10 was upregulated in the culture medium (the 1st, 2nd and 6th columns in Figure 2B -2E). As discussed regarding the basic properties of hAECs, the cell surface marker CD90 was partially expressed in the primary cultured hAECs, suggesting a distinct role of the CD90+ population.
To identify whether the CD90+ hAECs possessed a distinct function in immunomodulation, the CD90+ and CD90-hAECs were sorted using flow cytometry and were co-cultured with PBMCs ( Figure 2A ). The analysis of immunocytokines showed that CD90+ hAECs were the major contributors to hAECs ( Figure 2B, 2D) ; the decrease in IL17 could also be nearly completely attributed to CD90+ hAECs ( Figure 2C ).
the CD90+ and CD90-hAECs in the regulation of IL2 ( Figure  2E ).
Preclinical safety evaluation of hAECs
To assess the preclinical safety of the hAECs isolated and cultured in our system, a systematic safety evaluation was implemented. The toxicity test of hAECs was performed in ICR mice by intravenous injection. The most tolerance dose (MTD) and the no observed adverse effect level (NOAEL) (both were 5.0×10 7 cells/kg) were first identified. Further results of the acute toxicity test showed that both low-dose (the mouse equivalent dose) and high-dose (MTD) hAEC injections induced little toxic response, as evidenced by observations of mouse behavior, mental state, mortality and gross dissection (data not shown) and mouse body weight ( Figure 3A, 3B) .
Hemolytic and allergy tests were further performed in the recipient animals subjected to hAEC injection. The hemolytic test showed that along with an increased hAEC number, no cell suspension within 3 h ( Figure 3C ). On the other hand, similar to the negative control group, no allergic symptoms or associated death was identified in the guinea pigs receiving either a low dose or a high dose of hAECs ( Figure 3D, 3E) .
To determine the long-term toxicity of hAECs, body weight and viscera weight measurements, hematological examinations and basic histological examinations were performed after 3 hAEC injections in rats for 3 months. The Body weight measurements of male and female mice are shown in (A) and (B), respectively; n 6 6 hAECs shown in (E); n=3. results demonstrated that neither the low dose nor the high dose of hAECs affected rat body weight and viscera weight, routine blood parameters, blood biochemistry, or coagulation indexes, but minor changes in neutrophil, lymphocyte and monocyte ratios were observed (Table 2, 3) . However, infusion of a high dose of hAECs appeared to recover such changes. In addition, hAEC infusion did not disturb the immune system, as evidenced by little change in the T cell population (Table 4) and no induction of correlated cytokines (data not shown).
Tumorigenicity of hAECs
for clinical application. Therefore, the tumorigenesis of hAECs was determined via hypodermic injection into immunodeficient mice (NOD/SCID); melanoma cells were used as the positive control. Approximately 4 weeks post-injection, the mice receiving melanoma cells died, with melanoma manifesting subcutaneously. In contrast, neither the low-dose nor the high-dose injection of hAECs resulted in any tumor occurrence ( Figure 4A-4C ). The lack of the telomerase hTERT in hAECs may account for their negative tumorigenicity compared with human ES cells ( Figure 4D ). Furthermore, compared with the mice receiving tumor cell injection alone, the NOD/SCID mice receiving co-injection of hAECs with HeLa tumor cells demonstrated similar body weights and tumor volumes ( Figure 4E , 4F), and the NOD/SCID mice receiving co-injection of hAECs with Raji tumor cells demonstrated a similar survival duration ( Figure 4G ), indicating that hAECs have little effect on tumor growth.
Therapeutic effect of hAECs on radiation-induced damage in mice
The amniotic membrane-derived cells were considered effective for repairing injuries. To determine the healing ability of hAECs, a radiation-induced damage model was established in mice in the current study. The phenotypes of radiationinduced disease were initially observed in the control mice from the second week after sub-lethal radiation, including hair. In contrast, hAEC administration evidently alleviated the clinical phenotype of the radiation-induced damage according to body weight measurements and overall ratings ( Figure 5A-5C ). Consistently, histological examination of the lungs and intestines showed rescued pathological injuries in 
Discussion
Stem cells have been considered a promising source of seed cells for biological therapeutics and tissue engineering. However, in terms of clinical applications, several safety and ethical criteria are strictly required, which is currently the main limitation for general use of stem cells. In the current study, we focused on hAECs, a unique stem cell population isolated from the epithelium of the human amnion membrane. Targeting clinical application, we established a serum-free integrated system for isolating, culturing and cryopreserving hAECs. By excluding the animal-source constituents, this strategy could prevent serum-derived contamination and toxic effects on hAECs. Indeed, in the serum-free system, hAECs showed better growth ability, maintained regular morphology and cellular quiescence, and exhibited a high revival rate after cryopreservation. In addition, the serum-free system was able to stabilize hAEC quality as evidenced by consistent expression of surface markers and the purity of the hAEC population, indicating reliability and repeatability in the preclinical study. Importantly, low immunogenicity was detected in the hAECs isolated in the new system, indicating the feasibility of allotransplantation without a transplant matching issue. On the other hand, human AE, the origin of hAECs, is obtained from newborn waste and is therefore abundantly available without ethical concerns. Therefore, the hAEC isolation and culture system established in the current study may be an ideal approach for achieving a large-scale supply of seed cells with Similar to drugs, the safety of cellular products is considered a priority issue in clinical therapeutics. Therefore, a systemic safety evaluation was conducted on the hAECs following the pattern of drug safety evaluations. Although several basic studies have been conducted, very few safety evaluations have been performed for perinatal stem cells. To our knowledge, no observed adverse effect level (NOAEL) were both identified to be 2.5-fold greater than the mouse equivalent dose based on the clinical dose of MSC injection. Further results adverse effect on growth, behavior and general histology. In addition, the negative results of the hemolytic and allergy tests excluded disturbances of the blood system and the immune system induced by hAEC administration, which is supported by the detection of unvaried blood indexes and immune quiescence in the long-term toxicity test. All these results indicate the toxicity and histological safety of hAECs at a potential clinical dose. On the other hand, tumorigenicity is a major concern for stem cell products [24] . Several clinical trials on stem cell therapy have failed due to tumor generation [1, 25, 26] , which is caused primarily by reactivation of undifferentiated stem cells. MSCs were reported to promote tumor growth [27] . Therefore, tumor generation and tumor promotion properties in vivo and in vitro revealed that hAECs had no tumorigenicity.
Our examination of hAECs in nude mice also supported this conclusion (data not shown). These results ensure the other critical part of safety for the clinical application of hAECs.
Since the beginning of last century, amniotic tissue has been applied to repair burn injuries, ulcers and corneal disease. Recently, many studies have reported the therapeutic potential of hAECs in wound healing [21] . Our previous studies demonstrated the therapeutic effects of hAECs in kidney injury, alveolar defects, premature ovarian failure and ischemiareperfusion injury after middle cerebral artery occlusion [28] [29] [30] [31] . In the present study, we demonstrated the therapeutic effect of hAECs on radiation-induced damage. The results revealed a the biological activity of the hAECs cultured in the serum-free -ration could be attributed to the high degree of plasticity. As shown in the current study, hAECs exhibited higher levels of multipotent markers than MSCs cultured in a similar serumfree system; hAECs may have better plasticity among placenta stem cells based on their derivation from pregastrulation embryonic cells. Indeed, osteogenic, neural and granulosa cell differentiation was observed in our studies mentioned above, while our other study reported that hAECs could differentiate into functional insulin-producing cells [6] . Second, hAECs may maintain a stable cellular microenvironment to negatively modulate inflammation during injury, which could be due feto-maternal tolerance. Recent studies have revealed that -cytes caused by mixed lymphocyte reaction (MLR) or mitogen PHA [32] [33] [34] . Moreover, high levels of programmed death ligand indicating that hAECs inhibited the activation and proliferation of T lymphocytes by initiating their programmed death [32, 35] . On the other hand, hAECs were found to produce a variety of immunoregulatory factors, such as macrophage migration -tocyte growth factor, thereby suppressing the functions of [13, [35] [36] [37] . Consistent with this, our previous studies demonstrated the importance of hAEC paracrine activity for injury recovery in vivo [28, 38] CD90+ hAECs as a unique population with a powerful immufor the clinical application of hAECs. Our further studies will focus on targeted diseases and associated therapeutic strategies based on the current hAEC culture system.
